Platelet-rich fibrin-induced bone marrow mesenchymal stem cell differentiation into osteoblast-like cells and neural cells

Neural Regeneration Research

Volumn 6, Issue 31, 2011, Pages 2419-2423

  Li, Qi ^a   Geng, Yajun ^b   Lu, Lei ^c   Yang, Tingting ^a   Zhang, Mingrui ^a   Zhou, Yanmin ^a  

^a Hospital of Stomatology Jilin University   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c HARRISON INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Alkaline phosphatase; Bone marrow mesenchymal stem cells; Glial fibrillary acidic protein; Neural regeneration; Neuron specific enolase; Platelet rich fibrin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FIBRIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NEURON SPECIFIC ENOLASE; PLATELET RICH FIBRIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NERVE CELL; NONHUMAN; OSTEOBLAST; PROTEIN FUNCTION;

EID: 82555185062     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lavik E, Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol. 2004;65(1):1-8.
2. Yarlagadda PK, Chandrasekharan M, Shyan JY. Recent advances and current developments in tissue scaffolding. Biomed Mater Eng. 2005;15(3):159-177.
3. Grayson WL, Martens TP, Eng GM, et al. Biomimetic approach to tissue engineering. Semin Cell Dev Biol. 2009;20(6):665-673.
4. Choukroun J, Adda F, Schoeffler C, et al. Une opportunite 'en paro-implantologie: le PRF. Implantodontie. 2000;42:55-62.
5. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):45-50.
6. Lundquist R, Dziegiel MH, Agren MS. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound Repair Regen. 2008;16(3):356-363.
7. Sclafani AP. Applications of platelet-rich fibrin matrix in facial plastic surgery. Facial Plast Surg. 2009;25(4):270-276.
8. Aroca S, Keglevich T, Barbieri B, et al. Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol. 2009;80(2): 244-252.
9. Danielsen PL, Agren MS, Jorgensen LN. Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. Ann Surg. 2010;251(5):825-831.
10. Toffler M, Toscano N, Holtzclaw D. Osteotome-mediated sinus floor elevation using only platelet-rich fibrin: an early report on 110 patients. Implant Dent. 2010;19(5):447-456.
11. Farrag TY, Lehar M, Verhaegen P, et al. Effect of platelet rich plasma and fibrin sealant on facial nerve regeneration in a rat model. Laryngoscope. 2007;117(1):157-165.
12. Tan Z, Zhao Q, Gong P, et al. Research on promoting periodontal regeneration with human basic fibroblast growth factor-modified bone marrow mesenchymal stromal cell gene therapy. Cytotherapy. 2009;11(3):317-325.
13. Peng L, Ye L, Zhou XD. Mesenchymal stem cells and tooth engineering. Int J Oral Sci. 2009;1(1):6-12.
14. Haleem AM, Singergy AA, Sabry D, et al. The clinical use of human culture expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage. 2010;1(4):253-261.
15. Gilyarov AV. Nestin in central nervous system cells. Neurosci Behav Physiol. 2008;38(2):165-169.
16. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):37-44.
17. Snykers S, Vanhaecke T, Rogiers V. Isolation of rat bone marrow stem cells. Methods Mol Biol. 2006;320:265-272.
18. Beyer Nardi N, da Silva Meirelles L. Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol. 2006;174:249-282.
19. Gnecchi M, Melo LG. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol. 2009;482:281-294.
20. Choukroun JI, Braccini F, Dohan DM, et al. Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: a new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty? Rev Laryngol Otol Rhinol (Bord). 2007;128(1-2):27-32.
21. He L, Lin Y, Hu X, et al. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):707-713.
22. Chang IC, Tsai CH, Chang YC. Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A. 2010;95(1):327-332.
23. Douglas HE. TGF-ß in wound healing: a review. J Wound Care. 2010;19(9):403-406.
24. Graham S, Leonidou A, Lester M, et al. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs. 2009;18(11):1633-1654.
25. Lombardi G, Di Somma C, Vuolo L, et al. Role of IGF-I on PTH effects on bone. J Endocrinol Invest. 2010;33 (7 Suppl):22-26.
26. Kooijman R. Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev. 2006;17(4):305-323.
27. Iino S. Alkaline phosphatase (ALP). Nippon Rinsho. 1999; 57(Suppl):334-337.
28. Ghosh-Choudhury N, Harris MA, Feng JQ, et al. Expression of the BMP 2 gene during bone cell differentiation. Crit Rev Eukaryot Gene Expr. 1994;4(2-3):345-355.
29. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2010;339(1): 189-195.
30. Odagiri E. Neuron specific enolase (NSE). Nippon Rinsho. 1999; 57(Suppl):540-542.
31. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res. 2000; 25(9-10):1439-1451.
32. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006 09-30.
33. Guo XM, Wang CY, Wang YH, et al. Experimental study of the isolation, culture and in chondrogenic differentiation of human bone mesenchymal stem cell. Zhonghua Kou Qiang Yi Xue Za Zhi. 2003;38(1):63-66.
34. Romero-Ramirez L, Cao H, Regalado MP, et al. X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Transl Oncol. 2009;2(1):31-38.
35. Li H, Sun NL, Wang L. Circadian expression of clock genes and angiotensin II type 1 receptors in suprachiasmatic nuclei of sinoaortic-denervated rats. Acta Pharmacol Sin. 2007;28(4): 484-492.